adnexa

(redirected from adnexus)
Also found in: Thesaurus, Medical, Encyclopedia.

ad·nex·a

 (ăd-nĕk′sə)
pl.n.
Accessory or adjoining anatomical parts, as ovaries and fallopian tubes in relation to the uterus.

[Latin, neuter pl. of adnexus, past participle of adnectere, to bind to; see annex.]

ad·nex′al adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

adnexa

(ædˈnɛksə)
pl n
(Anatomy) anatomy adjoining organs, esp of the uterus
[C19: New Latin: appendages]
adˈnexal adj
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ad•nex•a

(ædˈnɛk sə)

n.pl.
appended or accessory anatomical parts, as the eyelids in relation to the eyes.
[1895–1900; < Latin, neuter pl. of adnexus physically attached, joined, past participle of adnectere to attach; see ad-, nexus]
ad•nex′al, adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.adnexa - accessory or adjoining anatomical parts or appendages to an organ (especially of the embryo)adnexa - accessory or adjoining anatomical parts or appendages to an organ (especially of the embryo); "Fallopian tubes and ovaries are adnexa of the uterus"
body part - any part of an organism such as an organ or extremity
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ad·nex·a

n., pl. anejos, anexos, apéndices tales como las trompas de Falopio.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
Prior to BMS, from 2009 to 2011, Bechtold served as vice president, Strategic Operations at Adnexus Therapeutics.
Previously, she was vice president Business Development at Adnexus Therapeutics.
Results for 2007 reflect the acquisition of Adnexus Therapeutics.
Some of the larger acquisitions of mAb producers by pharmaceutical companies this year were Bristol-Myers Squibb's purchase of Adnexus for $415 million in September and Roche's $56.5 million payout for Therapeutic Human Polyclonals in April.
In an effort to expand its cancer treatments, Bristol-Myers is acquiring developers of experimental medicines, such as Adnexus Therapeutics Inc., and has said it plans to seek approval by the end of the year for two other therapies, the bladder-cancer drug vinflunine and the melanoma medicine ipilimumab.